Delivery Order SPE2DB24D1201-SPE2DB26FJADK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) valued at $10,626.75. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count units) valued at $1,549.42. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) at a ceiling value of $1,761.65. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $12,799.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $11,788.95. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $5,755.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $36,113.23 on July 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,661.01 by the Defense Logistics Agency on August 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count). The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract valued at $8,276.16. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $49,303.22. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB26FJADKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $15,203.02. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio with the Defense Logistics Agency. The company supplies a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. All reviewed contract awards from AmerisourceBergen demonstrate competitive procurement practices with firm fixed pricing structures, reflecting the company's capability to meet federal healthcare supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 10/15/25 |